adalimumab-aqvh

Generic: Yusimry

40 mg/0.8 mL — Pen Injector

TARGETED IMMUNOMODULATORY BIOLOGICS

Also known as: YUSIMRY(CF) PEN

Coverage by Insurer

Informational only — Coverage rules change frequently; verify tier placement and restrictions with your plan or pharmacy before acting.
Source: CMS QHP JSON  ·  Checked: 16 hours, 31 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
AmeriHealth Caritas Next Silver Off-Marketplace Low + No Referrals
via Yusimry
Tier 5 - Specialty PA
AmeriHealth Caritas Next Silver Essential + No Referrals
via Yusimry
Tier 5 - Specialty PA
AmeriHealth Caritas Next Gold Premier + No Referrals
via Yusimry
Tier 5 - Specialty PA
AmeriHealth Caritas Next Bronze Essential + No Referrals
via Yusimry
Tier 5 - Specialty PA
AmeriHealth Caritas Next Bronze Signature + No Referrals
via Yusimry
Tier 5 - Specialty PA
AmeriHealth Caritas Next Silver Signature + No Referrals
via Yusimry
Tier 5 - Specialty PA
AmeriHealth Caritas Next Gold Signature + No Referrals
via Yusimry
Tier 5 - Specialty PA
AmeriHealth Caritas Next Silver Off-Marketplace High + No Referrals
via Yusimry
Tier 5 - Specialty PA
AmeriHealth Caritas Next Bronze Premier + No Referrals
via Yusimry
Tier 5 - Specialty PA
AmeriHealth Caritas Next Silver Premier + No Referrals
via Yusimry
Tier 5 - Specialty PA
Source: PDF  ·  Formulary date: Jul 1, 2026  ·  Checked: 16 hours, 31 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
NC Medicaid Preferred Drug List 2026
via Yusimry
Non-Preferred PA | ST
Source: Excel (XLSX)  ·  Formulary date: Jun 24, 2026  ·  Checked: 16 hours, 31 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
TRICARE Uniform Formulary 2026 Tier 3 - Non-Formulary PA
Something not right?